Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 0.55
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The test is based on database containing prostate cancer patients and provides decision support for patients...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers.
Data is available to registered users only
